UPTAKE - Virtual Care: Virtual Home Hospital With Remote Monitoring to Reduce Acute Care Hospitalization

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Calgary

About this trial

Method: Randomized Controlled Trial Study Duration: 3 Years Study Centre(s) University of Calgary and University of Alberta Objectives: To fill care gaps by implementing strategies to reduce length of hospital stay, readmission rates, and improve long-term outcomes after Acute Kidney Injury (AKI). Number of Participants: Three Hundred and fifty four (n=354) Diagnosis and Main Inclusion Criteria: Hospitalized adults with AKI at high risk of hospital readmission or death

Study Intervention: Multi-component Digital Health Solutions, including:

1. Computerized Clinical Decision Support (CDS) and 2. Virtual Care Delivered through Hospital at Home (VC) Duration of administration: Determined by the Patient's clinical team Reference therapy: Usual Care Statistical Analyses: Descriptive Analysis, Regression

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years old.

AKI identified in hospital using Kidney Disease Improving Global Outcomes (KDIGO) criteria17.

Hospitalization > 48 hours.

LACE (L= Length patient Stay in the hospital, A= Acuity of Admission of patient in the hospital, C= Comorbidity and E= Emergency Visit.) Score 12 or higher.

Disqualifiers

Non-Alberta residents.

Resides outside the catchment areas for the Calgary and Edmonton Virtual Home Hospital programs.

C1 or C2 goals of care.

Hospitalization > 30 days.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Virtual Care

    Other intervention

    Participants will go through Virtual hospital programs following the processes established by these programs in Alberta.

Treatment groups

354 Participants
are divided into 2 treatment groups
Group A: Virtual CareExperimental treatment 1 intervention
Group B: Usual CareNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

the number of days alive out of hospital

the number of days alive out of hospital

Time frame
Up to 45 days from the date of randomization

Secondary outcomes

1

the time as inpatient in hospital

the time as inpatient in hospital

Time frame
Up to 45 days from the date of randomization
2

death

death records from health administrative data.

Time frame
from the date of randomization up to 45 days, or date of death from any cause, whichever came first,
3

hospital readmission

hospital readmission records from health administrative data.

Time frame
Up to 45 days from the date of randomization
4

Emergency Department visits

Emergency Department visit records from health administrative data.

Time frame
Up to 45 days from the date of randomization

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Calgary

Lead sponsor

Alberta Health services

Collaborator